REG - FranklinResourcesInc Willis Towers Watson - Form 8.3 - WILLIS TOWERS WATSON PLC

Willis Towers WatsonAnnouncement

14/06/2021 14:15

RNS Number : 8361B
  
Franklin Resources, Inc
  
14 June 2021
  
 

 
Ap19
 
 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


  Franklin Resources, Inc.




Company dealt in


  WILLIS TOWERS WATSON PLC




Class of relevant security to which the dealings being disclosed relate (Note 2)


  
  US$0.000304635 ordinary shares




Date of dealing


  June 11, 2021




 
2.         INTERESTS AND SHORT POSITIONS
 
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


 1,715,679


1.33%


(980)


0.00%




(2) Derivatives (other than options)


 


 


 


 




(3) Options and agreements to purchase/sell


 


 


 


 




Total


1,715,679


1.33%


(980)


0.00%



 
 
 
 
 
 
 
 



 
(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)




Class of relevant security:


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


 


 




 
(2) Derivatives (other than options)


 


 




 
(3) Options and agreements to purchase/sell


 


 




Total


 


 



 
 
 
 
 
 
 




 

 
Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales.
 




 
Purchase/sale


 
Number of relevant securities


 
Price per unit (Note 5)




 


 


 




 
 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(Note 5)




 


 


 


 




 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




 


 


 


 


 


 


 




 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




Transfer in of discretionary holdings


8 shares


 





 

 
 
Ap21
 
2.       OTHER INFORMATION
 
Agreements, arrangements, or understandings relating to options or derivatives.
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and 
any other person relating to the voting rights of any relevant securities under any option referred to 
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 
which any derivative referred to on this form is referenced. If none, this should be stated.
 
 
                                        None
 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            NO
 




Date of disclosure


  June 14, 2021




Contact name


  Cathy Johnson




Telephone number


  954-527-7580




If a connected EFM, name of offeree/offeror with which connected


 




If a connected EFM, state nature of connection (Note 10)


 




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISEXZLFFFQLFBBB